Search research articles
Contact Us
Filters
Showing results (1-10 of 93) with videos related to
Page
of 10
Sort By:
JAMA
|
July 5, 2022
Nonsteroidal Topical Treatment for Plaque Psoriasis Is Approved
Howard D Larkin
JAMA
|
June 14, 2022
Urine Test Detects SARS-CoV-2 Antibodies
Howard D Larkin
JAMA
|
June 14, 2022
Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests
Howard D Larkin
JAMA
|
June 7, 2022
Targeting the Cause of Obstructive Hypertrophic Cardiomyopathy
Howard D Larkin
JAMA
|
July 12, 2022
Dual Anti-HIV Antibodies Provide Long-term Viral Suppression
Howard D Larkin
JAMA
|
July 19, 2022
Updated Malaria Recommendations for Children and Pregnant People
Howard D Larkin
JAMA
|
May 3, 2022
First Amphetamine Transdermal Patch Approved for ADHD
Howard D Larkin
JAMA
|
January 25, 2023
Ceasefire Declared, but Ethiopian Health Systems Remain in Critical Condition After Civil War
Howard D Larkin
JAMA
|
January 18, 2023
Lecanemab Gains FDA Approval for Early Alzheimer Disease
Howard D Larkin
JAMA
|
October 11, 2022
Trial Tests Combined Cell and Gene Therapy for ALS
Howard D Larkin
Page
of 10
Search research articles
Search
Showing results (1-10 of 93) with videos related to
Sort By:
Page
of 10
JAMA
|
July 5, 2022
Nonsteroidal Topical Treatment for Plaque Psoriasis Is Approved
Howard D Larkin
JAMA
|
June 14, 2022
Urine Test Detects SARS-CoV-2 Antibodies
Howard D Larkin
JAMA
|
June 14, 2022
Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests
Howard D Larkin
JAMA
|
June 7, 2022
Targeting the Cause of Obstructive Hypertrophic Cardiomyopathy
Howard D Larkin
JAMA
|
July 12, 2022
Dual Anti-HIV Antibodies Provide Long-term Viral Suppression
Howard D Larkin
JAMA
|
July 19, 2022
Updated Malaria Recommendations for Children and Pregnant People
Howard D Larkin
JAMA
|
May 3, 2022
First Amphetamine Transdermal Patch Approved for ADHD
Howard D Larkin
JAMA
|
January 25, 2023
Ceasefire Declared, but Ethiopian Health Systems Remain in Critical Condition After Civil War
Howard D Larkin
JAMA
|
January 18, 2023
Lecanemab Gains FDA Approval for Early Alzheimer Disease
Howard D Larkin
JAMA
|
October 11, 2022
Trial Tests Combined Cell and Gene Therapy for ALS
Howard D Larkin
Page
of 10